{
    "clinical_study": {
        "@rank": "5003", 
        "arm_group": [
            {
                "arm_group_label": "magnesium", 
                "arm_group_type": "Experimental", 
                "description": "magnesium is added perioperatively to those patients undergoing staged total knee arthroplasty and other surgeries."
            }, 
            {
                "arm_group_label": "ketamine", 
                "arm_group_type": "Experimental", 
                "description": "ketamine is administered to those patients undergoing stated TKA and other operations."
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "normal saline (placebo) is administered to the patients."
            }
        ], 
        "brief_summary": {
            "textblock": "NMDA receptor is administered and postoperative remote hyperalgesia is investigated."
        }, 
        "brief_title": "Hyperalgesia and NMDA Receptor Antagonist", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "condition_browse": {
            "mesh_term": "Hyperalgesia"
        }, 
        "detailed_description": {
            "textblock": "NMDA receptor is adminstered and postoperative tertiary hyperalgesia is investigated.\n\n      QST and pain measures for remote hyperalgesia are compared between control and magnesium or\n      ketamine group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA1-2\n\n        Exclusion Criteria:\n\n          -  contraindication to the study drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087202", 
            "org_study_id": "hyperalgesia"
        }, 
        "intervention": [
            {
                "arm_group_label": "magnesium", 
                "description": "magnesium sulfate is added to the patients", 
                "intervention_name": "Magnesium Sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ketamine", 
                "description": "ketamine is added to the patients.", 
                "intervention_name": "ketamine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketamine", 
                "Magnesium Sulfate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "pain", 
        "lastchanged_date": "March 12, 2014", 
        "number_of_arms": "3", 
        "official_title": "Hyperalgesia and NMDA Receptor Antagonist", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "pain (QST and pain measures )until 1 month from the end of the operation", 
            "measure": "pain", 
            "safety_issue": "Yes", 
            "time_frame": "until 1 month from the end of the operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087202"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul St. Mary's Hospital", 
            "investigator_full_name": "Kim Mihyun", 
            "investigator_title": "clinical professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}